IRDAI directs insurers to avoid investments in overseas AIFs
The Insurance Regulatory and Development Authority of India has directed insurers not to invest in overseas Alternative Investment Funds, reinforcing restrictions under existing regulatory norms.
The regulator said statutory auditors of AIFs must confirm that insurer capital is not invested outside India. Insurers are also required to obtain a compliance certificate from the AIF confirming that any overseas investments are fully disclosed. Additionally, the concurrent auditor of the insurer must certify adherence to excusal rights provisions in respect of investments in AIFs with overseas exposure.
Under Section 27E of the Insurance Act, 1938 and related rules framed by the Securities and Exchange Board of India, insurers have strict excusal rights that prohibit exposure to foreign investments through AIF structures.
The move aims to ensure that insurance funds remain within permitted domestic investment avenues and comply with prudential norms governing capital deployment.
IRDAI Urges Insurers to Cut Costs to Improve Health Cover Affordability
The Insurance Regulatory and Development Authority of India has asked insurers to rationalise operating and distribution costs to make health insurance policies more affordable for consumers, amid concerns over rising premiums and limited penetration.
The regulator has emphasised that high acquisition expenses, including commissions and administrative overheads, are contributing to elevated premium levels. Insurers have been advised to review expense structures, streamline processes and improve efficiency so that cost savings can be passed on to policyholders.
The direction comes at a time when healthcare inflation continues to exert pressure on claims payouts, making affordability a critical concern for households. IRDAI has reiterated that improving insurance coverage requires balancing sustainable underwriting with reasonable pricing.
Officials have also highlighted the need to strengthen claims management, reduce leakages and enhance transparency in distribution practices. By addressing cost inefficiencies, insurers can widen access to health coverage and improve penetration, particularly in underinsured segments.
The regulator’s intervention aligns with the broader objective of expanding insurance coverage under the “Insurance for All” vision. Policymakers have increasingly pointed to high distribution costs and operational inefficiencies as structural challenges that must be addressed to enhance affordability.
Industry participants are expected to engage with the regulator on measures such as better use of digital channels, simplified products and disciplined expense management frameworks. The move signals continued regulatory focus on consumer protection, pricing fairness and sustainable growth within the health insurance segment.
IRDAI Facilitating Insurer–Hospital Dialogue to Streamline Health Insurance
The Insurance Regulatory and Development Authority of India is actively encouraging structured dialogue between insurers and hospitals to address persistent frictions in the health insurance ecosystem, according to Chairman Ajay Seth.
Speaking on efforts to improve the functioning of health insurance, Seth said the regulator is pushing for greater coordination between payers and healthcare providers to resolve disputes related to pricing, claims settlement and treatment protocols. He indicated that misalignment between insurers and hospitals has often resulted in delays, claim rejections and customer dissatisfaction.
The regulator is seeking to improve transparency in hospital billing, standardise treatment pathways and reduce ambiguities that lead to disputes during cashless approvals. Strengthening common platforms and data-sharing mechanisms is also being explored to enhance efficiency and trust across the value chain.
IRDAI Reduces Health Insurance Moratorium to Five Years
The Insurance Regulatory and Development Authority of India has reduced the moratorium period for health insurance policies from eight years to five years, in a move aimed at strengthening policyholder protection and improving customer confidence.
Under the revised framework, insurers will not be permitted to contest a health insurance policy after it has been in force for five continuous years, except in cases involving proven fraud or deliberate misrepresentation. Earlier, the moratorium period stood at eight years, allowing insurers a longer window to review and potentially repudiate claims based on non-disclosure or other grounds.
The regulator said the change is intended to enhance transparency and reduce uncertainty for policyholders. By shortening the moratorium timeline, long-standing customers gain greater assurance that their claims will not be rejected on technical grounds after prolonged policy tenure.
The reform is expected to encourage policy persistency and support the broader objective of deepening health insurance penetration. It also aligns with ongoing regulatory measures to standardise policy terms, streamline claims handling and promote fair treatment of customers.
Industry observers note that insurers will need to strengthen underwriting and initial risk assessment processes, as the shorter contestability window increases the importance of accurate proposal evaluation at the outset.
Niva Bupa Under IRDAI Scrutiny Amid Regulatory Review
Niva Bupa Health Insurance has come under regulatory scrutiny as the Insurance Regulatory and Development Authority of India intensifies oversight of insurers’ compliance and expense management practices.
According to reports, the regulator has sought clarifications from the health insurer as part of a broader review focused on governance standards, distribution costs and adherence to regulatory norms. The scrutiny forms part of IRDAI’s ongoing supervisory engagement with insurers to ensure that business practices align with prescribed expense limits and conduct requirements.
The heightened regulatory attention follows sector-wide concerns over rising acquisition costs, commission structures and the need to strengthen transparency in distribution practices. IRDAI has in recent months emphasised disciplined underwriting, tighter expense control and improved policyholder protection mechanisms across the industry.
While no formal penalty has been announced in connection with the current review, industry observers note that such examinations typically involve detailed submissions and potential hearings before any regulatory action is finalised. The regulator has been increasingly proactive in seeking explanations from insurers where deviations from norms are identified.
The development comes at a time when the health insurance segment is witnessing rapid growth, driven by higher risk awareness and expanding coverage. As competition intensifies, regulators are seeking to balance market expansion with robust compliance frameworks.
The case underscores the regulator’s continued focus on governance, transparency and sustainable growth within India’s evolving health insurance landscape.
